Sunnybrook Research Institute, Odette Cancer Center

Toronto, Ontario M4N 3M5

1 studies enrolling now · 3 studies all time

What they study most

Metastatic Castration-Resistant Prostate Cancer, Myelodysplastic Syndromes, Prostate Cancer

Studies at this site

• A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions — Recruiting now
• Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment — Running, not enrolling
• Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer — Completed